[ad_1]
Johnson and Johnson have agreed to stop selling opioids in the US as part of a $ 230m deal with the New York government to address cases that have contributed to the spread of the painkillers.
The company, which produced opioids in combination with fentanyl skin and tablets, declined to comment but stopped producing and distributing opioids in the US.
The settlement is part of a series of more than 3,000 lawsuits in the US seeking to force opioid producers and distributors to take part in the financial crisis that officials are blaming for their drug trafficking.
The Centers for Disease Control and Prevention estimates that the opioid estimate has killed 500,000 Americans over two decades. Many deaths are related to painkillers manufactured by drug manufacturers and prescribed by doctors.
In the process, J&J has avoided going to court next week, when the New York government is due to meet with opioid manufacturers and co-distributors in court.
“The opioid epidemic has devastated many people in New York State and the rest of the country, leaving millions of people still on dangerous and dangerous opioids,” said New York Attorney General Letitia James.
“Johnson & Johnson helped ignite the fire, but today they are committed to giving up the opioid business – not only in New York, but throughout the country,” he said.
James added that the sale of opioid oil products was slightly encouraged by the increase in sales.
J&J said “its actions in marketing and promoting essential herbal remedies were appropriate and reliable”.
In March 2019, James filed a lawsuit against opioid manufacturers and distributors. In addition to J&J, Purdue Pharma and members of the Sackler, Mallinckrodt, Endo, and Teva family members are among others. It also included distributors including McKesson, Cardinal Health and Amerisource Bergen.
Prosecution charges against Purdue Pharma and the Sackler and Mallinckrodt families are pending in the US Bankruptcy Court. The trial is set to begin next week.
In August, J&J was ordered by a judge in Oklahoma to pay $ 465m after he was found guilty in a 2019 opioid drug trafficking case.
[ad_2]
Source link
